Trial intelligence / Profile preview

Dexmedetomidine vs Fentanyl in TAP Block for Inguinal Hernia

NCT04971759Phase 3Completed

Sponsor
Assiut University
Start
Dec 2019
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoint: Time to first analgesic request at 24 hours. Started Dec 2019; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04971759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04971759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call